A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease.
Parkinsonism Relat Disord
; 110: 105367, 2023 05.
Article
in English
| MEDLINE | ID: covidwho-2267408
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Parkinson Disease
/
Cognition Disorders
/
Cognitive Dysfunction
Type of study:
Experimental Studies
/
Prognostic study
/
Qualitative research
/
Randomized controlled trials
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Parkinsonism Relat Disord
Journal subject:
Neurology
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS